MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), announced today the development of an innovative technology, the Classical Boosted Quantum Optimization Algorithm (CBQOA). This algorithm ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Two PROTAC synergy using two E3 ligases for achieving levels of degradation of KRAS G12D not achieved with single PROTACs, ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

A new technical paper titled “Advanced Chiplet Placement and Routing Optimization considering Signal Integrity” was published by researchers at KAIST. Abstract: “This article addresses the critical ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Cold” tumors are resistant to common immunotherapies. Stanford Medicine researchers have uncovered a master regulator that ...

The DVLA has banned a number of new plates for the upcoming '75' release in September due to their potential to be construed as offensive, provocative or otherwise unsuitable ...

Akoya Biosciences (AKYA) announced a collaboration with the Singapore Translational Cancer Consortium on the STCC Unified PD1/PDL1 Evaluation ...